CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
Background: CXCL13 is preferentially secreted by Follicular Helper T cells (TFH) to attract B cells to germinal centers. Plasma levels of CXCL13 have been reported to be elevated during chronic HIV-infection, however there is limited data on such elevation during early phases of infection and on the...
Main Authors: | Vikram Mehraj, Rayoun Ramendra, Stéphane Isnard, Franck P. Dupuy, Bertrand Lebouché, Cecilia Costiniuk, Réjean Thomas, Jason Szabo, Jean-Guy Baril, Benoit Trottier, Pierre Coté, Roger LeBlanc, Madéleine Durand, Carl Chartrand-Lefebvre, Ido Kema, Yonglong Zhang, Malcolm Finkelman, Cécile Tremblay, Jean-Pierre Routy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00289/full |
Similar Items
-
Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation
by: Rayoun Ramendra, et al.
Published: (2019-03-01) -
Fungal microbial translocation changes during treated acute and chronic HIV infection
by: Vikram Mehraj, et al.
Published: (2018-05-01) -
The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
by: Vikram Mehraj, et al.
Published: (2017-10-01) -
Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
by: Jean-Pierre Routy, et al.
Published: (2017-09-01) -
Soluble ST2 rings the alarm for gut damage and immune activation in primary HIV infection
by: Vikram Mehraj, et al.
Published: (2016-05-01)